Gout Trial, Recruiting (NCT04695028)

Gout Trial, Recruiting NCT04695028 Sponsor: Lille Catholic University Condition: Gout

Printed from Voxsanity (voxsanity.com.au) — NCT04695028 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gout

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with gout (based on 2015 medical guidelines), OR a condition called calcium pyrophosphate crystal disease (CPPD), OR a condition called hydroxyapatite crystal rheumatism (HCR), where calcium deposits are visible on medical scans
You are someone who has had, or would benefit from, a special type of ultrasound scan and/or a special X-ray scan (called DECT) to look for crystal deposits in the joints
Your doctor suspects you may have a crystal-related joint condition and needs further scans to confirm the diagnosis

Who may not be able to join:

You are unable or unwilling to have an ultrasound or DECT scan for any reason
You do not agree to allow your health information to be used for research purposes
You are under legal guardianship or a similar form of supervised legal protection
You are pregnant
You are not enrolled in or entitled to French social security (or an equivalent scheme) (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tristan Pascart, MD, GHICL

Phone: 0033320225269

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04695028

Sponsor: Lille Catholic University

Phase: Not Applicable

Status: Recruiting

Condition: Gout

Trial contact: 0033320225269

More information: https://clinicaltrials.gov/study/NCT04695028

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with gout (based on 2015 medical guidelines), OR a condition called calcium pyrophosphate crystal disease (CPPD), OR a condition called hydroxyapatite crystal rheumatism (HCR), where calcium deposits are visible on medical scans
You are someone who has had, or would benefit from, a special type of ultrasound scan and/or a special X-ray scan (called DECT) to look for crystal deposits in the joints
Your doctor suspects you may have a crystal-related joint condition and needs further scans to confirm the diagnosis

Who may not be able to join:

You are unable or unwilling to have an ultrasound or DECT scan for any reason
You do not agree to allow your health information to be used for research purposes
You are under legal guardianship or a similar form of supervised legal protection
You are pregnant
You are not enrolled in or entitled to French social security (or an equivalent scheme) (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Lille Catholic University

Registry

ClinicalTrials.gov

Start date

16 March 2021

Est. completion

1 October 2023

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Diagnosis of microcrystalline rheumatism; Weight; Height; Index body mass; Comorbidities; Number of rheumatic flares; Intensity of rheumatic flares; Identification of subcutaneous tophi; Uricemia; Renal function panel; Lipid profile

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov